1. Home
  2. FRPT vs SUPN Comparison

FRPT vs SUPN Comparison

Compare FRPT & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshpet Inc.

FRPT

Freshpet Inc.

HOLD

Current Price

$64.17

Market Cap

2.9B

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$50.07

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRPT
SUPN
Founded
2004
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.9B
IPO Year
2014
2012

Fundamental Metrics

Financial Performance
Metric
FRPT
SUPN
Price
$64.17
$50.07
Analyst Decision
Buy
Strong Buy
Analyst Count
16
5
Target Price
$76.33
$61.60
AVG Volume (30 Days)
923.5K
628.9K
Earning Date
02-19-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
169.38
N/A
EPS
2.38
N/A
Revenue
$1,079,494,000.00
$681,539,000.00
Revenue This Year
$15.47
$8.32
Revenue Next Year
$9.50
$23.64
P/E Ratio
$26.55
N/A
Revenue Growth
16.34
4.54
52 Week Low
$46.76
$29.16
52 Week High
$164.07
$57.65

Technical Indicators

Market Signals
Indicator
FRPT
SUPN
Relative Strength Index (RSI) 59.07 51.47
Support Level $60.98 $49.41
Resistance Level $64.49 $52.34
Average True Range (ATR) 2.32 1.54
MACD -0.05 -0.13
Stochastic Oscillator 79.15 48.19

Price Performance

Historical Comparison
FRPT
SUPN

About FRPT Freshpet Inc.

Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (96% of 2024 sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 98% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: